

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | piRNA metabolic process (GO:0034587) | 7.43317347 |
| 2 | female gamete generation (GO:0007292) | 6.46254605 |
| 3 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 6.40492893 |
| 4 | regulation of meiosis (GO:0040020) | 6.18728139 |
| 5 | mitotic chromosome condensation (GO:0007076) | 6.15166052 |
| 6 | meiotic cell cycle (GO:0051321) | 5.82348429 |
| 7 | regulation of female gonad development (GO:2000194) | 5.65959859 |
| 8 | mitotic metaphase plate congression (GO:0007080) | 5.56596435 |
| 9 | regulation of meiosis I (GO:0060631) | 5.43199100 |
| 10 | histone H2A monoubiquitination (GO:0035518) | 5.23927068 |
| 11 | regulation of sister chromatid cohesion (GO:0007063) | 5.16769423 |
| 12 | regulation of exit from mitosis (GO:0007096) | 5.14272853 |
| 13 | DNA damage induced protein phosphorylation (GO:0006975) | 5.06724321 |
| 14 | oocyte maturation (GO:0001556) | 5.01501451 |
| 15 | negative regulation of hormone metabolic process (GO:0032351) | 4.98757848 |
| 16 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.98757848 |
| 17 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 4.97134000 |
| 18 | negative regulation of meiosis (GO:0045835) | 4.96570744 |
| 19 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.94393388 |
| 20 | mitotic sister chromatid segregation (GO:0000070) | 4.93155372 |
| 21 | female gonad development (GO:0008585) | 4.86601065 |
| 22 | metaphase plate congression (GO:0051310) | 4.86081324 |
| 23 | establishment of chromosome localization (GO:0051303) | 4.85359834 |
| 24 | regulation of meiotic cell cycle (GO:0051445) | 4.84296706 |
| 25 | glycerophospholipid catabolic process (GO:0046475) | 4.79992218 |
| 26 | DNA methylation involved in gamete generation (GO:0043046) | 4.75229339 |
| 27 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 4.75056600 |
| 28 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.74276447 |
| 29 | male meiosis (GO:0007140) | 4.55636040 |
| 30 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 4.51321616 |
| 31 | attachment of spindle microtubules to kinetochore (GO:0008608) | 4.50509503 |
| 32 | L-phenylalanine catabolic process (GO:0006559) | 4.48417158 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.48417158 |
| 34 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 4.41527662 |
| 35 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 4.32789693 |
| 36 | DNA alkylation (GO:0006305) | 4.29404869 |
| 37 | DNA methylation (GO:0006306) | 4.29404869 |
| 38 | histone H2A ubiquitination (GO:0033522) | 4.29189211 |
| 39 | type B pancreatic cell development (GO:0003323) | 4.27508412 |
| 40 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.25990663 |
| 41 | L-phenylalanine metabolic process (GO:0006558) | 4.23593150 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.23593150 |
| 43 | ether lipid metabolic process (GO:0046485) | 4.19740005 |
| 44 | regulation of RIG-I signaling pathway (GO:0039535) | 4.16600430 |
| 45 | maturation of 5.8S rRNA (GO:0000460) | 4.15253855 |
| 46 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 4.15120746 |
| 47 | regulation of histone H3-K27 methylation (GO:0061085) | 4.15006160 |
| 48 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.08510909 |
| 49 | sister chromatid segregation (GO:0000819) | 4.03304833 |
| 50 | meiotic chromosome segregation (GO:0045132) | 3.99979772 |
| 51 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.93813567 |
| 52 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.93813567 |
| 53 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.93064935 |
| 54 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.80187402 |
| 55 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.79114174 |
| 56 | gene silencing by RNA (GO:0031047) | 3.78572163 |
| 57 | interkinetic nuclear migration (GO:0022027) | 3.76362499 |
| 58 | oogenesis (GO:0048477) | 3.75186098 |
| 59 | negative regulation of circadian rhythm (GO:0042754) | 3.74818825 |
| 60 | triglyceride catabolic process (GO:0019433) | 3.74498328 |
| 61 | notochord development (GO:0030903) | 3.73629190 |
| 62 | microtubule severing (GO:0051013) | 3.71024116 |
| 63 | negative regulation of meiotic cell cycle (GO:0051447) | 3.70981910 |
| 64 | biotin metabolic process (GO:0006768) | 3.69870437 |
| 65 | snRNA transcription (GO:0009301) | 3.69146017 |
| 66 | kinetochore organization (GO:0051383) | 3.67347774 |
| 67 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.66658286 |
| 68 | microtubule nucleation (GO:0007020) | 3.66297999 |
| 69 | regulation of spindle organization (GO:0090224) | 3.65918101 |
| 70 | mitotic nuclear envelope disassembly (GO:0007077) | 3.65600153 |
| 71 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.65349625 |
| 72 | kinetochore assembly (GO:0051382) | 3.64193369 |
| 73 | regulation of acrosome reaction (GO:0060046) | 3.62388975 |
| 74 | protein localization to chromosome, centromeric region (GO:0071459) | 3.59540814 |
| 75 | chromosome segregation (GO:0007059) | 3.58925464 |
| 76 | fatty acid homeostasis (GO:0055089) | 3.56893629 |
| 77 | protein localization to chromosome (GO:0034502) | 3.56149040 |
| 78 | glycine metabolic process (GO:0006544) | 3.56033962 |
| 79 | serine family amino acid catabolic process (GO:0009071) | 3.55818544 |
| 80 | opioid receptor signaling pathway (GO:0038003) | 3.54711778 |
| 81 | positive regulation of chromosome segregation (GO:0051984) | 3.53094520 |
| 82 | regulation of DNA methylation (GO:0044030) | 3.51455524 |
| 83 | neutral lipid catabolic process (GO:0046461) | 3.49842397 |
| 84 | acylglycerol catabolic process (GO:0046464) | 3.49842397 |
| 85 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.49580780 |
| 86 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.49580780 |
| 87 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.49580780 |
| 88 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.47999521 |
| 89 | nuclear envelope disassembly (GO:0051081) | 3.47823757 |
| 90 | membrane disassembly (GO:0030397) | 3.47823757 |
| 91 | cytoskeleton-dependent cytokinesis (GO:0061640) | 3.46177387 |
| 92 | regulation of mitotic spindle organization (GO:0060236) | 3.45967327 |
| 93 | centriole replication (GO:0007099) | 3.45061486 |
| 94 | mitotic sister chromatid cohesion (GO:0007064) | 3.40488932 |
| 95 | regulation of chromosome segregation (GO:0051983) | 3.40277722 |
| 96 | negative regulation of histone methylation (GO:0031061) | 3.37933268 |
| 97 | protein localization to kinetochore (GO:0034501) | 3.37823494 |
| 98 | parturition (GO:0007567) | 3.35965378 |
| 99 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.35834095 |
| 100 | behavioral response to ethanol (GO:0048149) | 3.35746726 |
| 101 | spindle checkpoint (GO:0031577) | 3.32873306 |
| 102 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.31153999 |
| 103 | negative regulation of reproductive process (GO:2000242) | 3.30846076 |
| 104 | CENP-A containing nucleosome assembly (GO:0034080) | 3.29887424 |
| 105 | ethanol oxidation (GO:0006069) | 3.29869583 |
| 106 | DNA replication checkpoint (GO:0000076) | 3.29039236 |
| 107 | protein K6-linked ubiquitination (GO:0085020) | 3.26903123 |
| 108 | omega-hydroxylase P450 pathway (GO:0097267) | 3.25253735 |
| 109 | DNA replication-independent nucleosome organization (GO:0034724) | 3.23385746 |
| 110 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.23385746 |
| 111 | protein carboxylation (GO:0018214) | 3.23350824 |
| 112 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.23350824 |
| 113 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.23119513 |
| 114 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.22859833 |
| 115 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.19800548 |
| 116 | regulation of cell cycle G2/M phase transition (GO:1902749) | 3.18626494 |
| 117 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.18541753 |
| 118 | regulation of mononuclear cell migration (GO:0071675) | 3.17694715 |
| 119 | glyoxylate metabolic process (GO:0046487) | 3.17431485 |
| 120 | glycerolipid catabolic process (GO:0046503) | 3.16779202 |
| 121 | cellular ketone body metabolic process (GO:0046950) | 3.16613183 |
| 122 | chromatin remodeling at centromere (GO:0031055) | 3.15011675 |
| 123 | forebrain morphogenesis (GO:0048853) | 3.14129082 |
| 124 | regulation of gene expression by genetic imprinting (GO:0006349) | 3.14024634 |
| 125 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.12701312 |
| 126 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.12067493 |
| 127 | regulation of centriole replication (GO:0046599) | 3.11797902 |
| 128 | regulation of macrophage chemotaxis (GO:0010758) | 3.11442055 |
| 129 | negative regulation of cell division (GO:0051782) | 3.10444910 |
| 130 | regulation of G2/M transition of mitotic cell cycle (GO:0010389) | 3.09728905 |
| 131 | central nervous system myelination (GO:0022010) | 3.04455808 |
| 132 | axon ensheathment in central nervous system (GO:0032291) | 3.04455808 |
| 133 | adult feeding behavior (GO:0008343) | 3.02210752 |
| 134 | positive regulation by host of viral transcription (GO:0043923) | 3.00851528 |
| 135 | short-chain fatty acid metabolic process (GO:0046459) | 3.00224294 |
| 136 | regulation of protein activation cascade (GO:2000257) | 2.95069110 |
| 137 | regulation of complement activation (GO:0030449) | 2.84469445 |
| 138 | carnitine shuttle (GO:0006853) | 2.84319587 |
| 139 | white fat cell differentiation (GO:0050872) | 2.82933494 |
| 140 | fatty acid transmembrane transport (GO:1902001) | 2.82714935 |
| 141 | quaternary ammonium group transport (GO:0015697) | 2.76928284 |
| 142 | blood coagulation, intrinsic pathway (GO:0007597) | 2.75867245 |
| 143 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.72564877 |
| 144 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.72030144 |
| 145 | aromatic amino acid family catabolic process (GO:0009074) | 2.71417595 |
| 146 | ketone body metabolic process (GO:1902224) | 2.71264684 |
| 147 | urea metabolic process (GO:0019627) | 2.70295918 |
| 148 | plasma lipoprotein particle clearance (GO:0034381) | 2.68215806 |
| 149 | serine family amino acid metabolic process (GO:0009069) | 2.66574125 |
| 150 | definitive hemopoiesis (GO:0060216) | 2.64013097 |
| 151 | complement activation, alternative pathway (GO:0006957) | 2.63622466 |
| 152 | epoxygenase P450 pathway (GO:0019373) | 2.63126065 |
| 153 | thyroid gland development (GO:0030878) | 2.61959324 |
| 154 | serine family amino acid biosynthetic process (GO:0009070) | 2.60999386 |
| 155 | acylglycerol homeostasis (GO:0055090) | 2.60906064 |
| 156 | triglyceride homeostasis (GO:0070328) | 2.60906064 |
| 157 | amino-acid betaine metabolic process (GO:0006577) | 2.60040188 |
| 158 | carnitine transmembrane transport (GO:1902603) | 2.57800146 |
| 159 | negative regulation of granulocyte differentiation (GO:0030853) | 2.56198454 |
| 160 | regulation of translational termination (GO:0006449) | 2.56113175 |
| 161 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.54215200 |
| 162 | L-serine metabolic process (GO:0006563) | 2.53433326 |
| 163 | negative regulation of fibrinolysis (GO:0051918) | 2.52248769 |
| 164 | amino-acid betaine transport (GO:0015838) | 2.51244639 |
| 165 | carnitine transport (GO:0015879) | 2.51244639 |
| 166 | urea cycle (GO:0000050) | 2.50825662 |
| 167 | ethanol metabolic process (GO:0006067) | 2.50491935 |
| 168 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.50232100 |
| 169 | regulation of fibrinolysis (GO:0051917) | 2.49226913 |
| 170 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.48992356 |
| 171 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.48172058 |
| 172 | negative regulation of sterol transport (GO:0032372) | 2.40237277 |
| 173 | negative regulation of cholesterol transport (GO:0032375) | 2.40237277 |
| 174 | nitrogen cycle metabolic process (GO:0071941) | 2.39212938 |
| 175 | nitric oxide mediated signal transduction (GO:0007263) | 2.38821277 |
| 176 | heart trabecula formation (GO:0060347) | 2.36341459 |
| 177 | alpha-amino acid catabolic process (GO:1901606) | 2.34887383 |
| 178 | low-density lipoprotein particle clearance (GO:0034383) | 2.29317686 |
| 179 | response to parathyroid hormone (GO:0071107) | 2.29315948 |
| 180 | protein-lipid complex remodeling (GO:0034368) | 2.29156333 |
| 181 | macromolecular complex remodeling (GO:0034367) | 2.29156333 |
| 182 | plasma lipoprotein particle remodeling (GO:0034369) | 2.29156333 |
| 183 | astrocyte development (GO:0014002) | 2.28810731 |
| 184 | glucose catabolic process (GO:0006007) | 2.28736760 |
| 185 | response to nitrosative stress (GO:0051409) | 2.27644786 |
| 186 | positive regulation of gluconeogenesis (GO:0045722) | 2.27260797 |
| 187 | fatty acid beta-oxidation (GO:0006635) | 2.26902149 |
| 188 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.26766480 |
| 189 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.25967073 |
| 190 | fatty acid catabolic process (GO:0009062) | 2.25777747 |
| 191 | fatty acid oxidation (GO:0019395) | 2.24553183 |
| 192 | intestinal cholesterol absorption (GO:0030299) | 2.23759590 |
| 193 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.22620762 |
| 194 | collecting duct development (GO:0072044) | 2.21955113 |
| 195 | monocarboxylic acid catabolic process (GO:0072329) | 2.21768957 |
| 196 | negative regulation of fatty acid transport (GO:2000192) | 2.20982672 |
| 197 | negative regulation of gluconeogenesis (GO:0045721) | 2.20073235 |
| 198 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.20010507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.90540730 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.46407347 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.25890495 |
| 4 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 4.08330170 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.97129750 |
| 6 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.91879712 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.57102976 |
| 8 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.23898557 |
| 9 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 3.09827591 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.02111564 |
| 11 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.78529232 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66855560 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.63514182 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.58197993 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.51469941 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44681048 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43451272 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.27100456 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.26279073 |
| 20 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.20336413 |
| 21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.20112919 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.18773328 |
| 23 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.11302506 |
| 24 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.08995583 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.07984469 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97944140 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.96206623 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87315470 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.87037904 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.85280670 |
| 31 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85220595 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.79704421 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77860061 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77099441 |
| 35 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.76581293 |
| 36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.75897355 |
| 37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.75897355 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74257364 |
| 39 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.72803756 |
| 40 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.71975613 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71007951 |
| 42 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.69239090 |
| 43 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.69106611 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.68861993 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.68051782 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.66044650 |
| 47 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.65113539 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64696505 |
| 49 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.63599809 |
| 50 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.62990960 |
| 51 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.62270586 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60859821 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60556147 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59508390 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59255621 |
| 56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.59241813 |
| 57 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.58131431 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.57466350 |
| 59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57344730 |
| 60 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56484913 |
| 61 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.55774431 |
| 62 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.53424515 |
| 63 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.52978740 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51792699 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50941965 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48325000 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.47977777 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47852754 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44403326 |
| 70 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44154892 |
| 71 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.44150097 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43349519 |
| 73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43099265 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.41750352 |
| 75 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.41349562 |
| 76 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.39988691 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.39439645 |
| 78 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.38165100 |
| 79 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.37614680 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37605920 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.37442666 |
| 82 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.36904557 |
| 83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34696635 |
| 84 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32588151 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32569515 |
| 86 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.31721661 |
| 87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31575877 |
| 88 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31103065 |
| 89 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30893744 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30442532 |
| 91 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30359052 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30084885 |
| 93 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.28813992 |
| 94 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.28740673 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28197742 |
| 96 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.27705864 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27517566 |
| 98 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.26229909 |
| 99 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26197689 |
| 100 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.25998490 |
| 101 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.25917310 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25166798 |
| 103 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.24005099 |
| 104 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.23252321 |
| 105 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.21510527 |
| 106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20949704 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20469513 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19988193 |
| 109 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.19890595 |
| 110 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19798175 |
| 111 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.19759679 |
| 112 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.18161010 |
| 113 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17321607 |
| 114 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.16665936 |
| 115 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.16540741 |
| 116 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.16103023 |
| 117 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.15945789 |
| 118 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.14653294 |
| 119 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14501889 |
| 120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13489618 |
| 121 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13258715 |
| 122 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.13053113 |
| 123 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.11833807 |
| 124 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11828276 |
| 125 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11828276 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.10422552 |
| 127 | NFYA_21822215_ChIP-Seq_K562_Human | 1.10015139 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09186407 |
| 129 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07870361 |
| 130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07365810 |
| 131 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.07198017 |
| 132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06783159 |
| 133 | TBL1_22424771_ChIP-Seq_293T_Human | 1.06655080 |
| 134 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06599802 |
| 135 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06440861 |
| 136 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.06395929 |
| 137 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06285808 |
| 138 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.06095171 |
| 139 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06072291 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04918731 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04508552 |
| 142 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04236009 |
| 143 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.03867353 |
| 144 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03664684 |
| 145 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.02934077 |
| 146 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02195086 |
| 147 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02184621 |
| 148 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02137206 |
| 149 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01321764 |
| 150 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.99842917 |
| 151 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99480366 |
| 152 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99151376 |
| 153 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98542136 |
| 154 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98245823 |
| 155 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97783802 |
| 156 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95294630 |
| 157 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94927528 |
| 158 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94269400 |
| 159 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.94063773 |
| 160 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.93447594 |
| 161 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92748721 |
| 162 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92567389 |
| 163 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91379744 |
| 164 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90645297 |
| 165 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90584500 |
| 166 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90337305 |
| 167 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89464197 |
| 168 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89347696 |
| 169 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89081806 |
| 170 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88669828 |
| 171 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88531080 |
| 172 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88408544 |
| 173 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.88362347 |
| 174 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.88278952 |
| 175 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88141794 |
| 176 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.87771566 |
| 177 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.87593224 |
| 178 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.87030907 |
| 179 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.86659448 |
| 180 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86457155 |
| 181 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86457155 |
| 182 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.86140649 |
| 183 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.86030154 |
| 184 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.85869502 |
| 185 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.85774925 |
| 186 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85299258 |
| 187 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84764167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003718_maternal_effect | 6.71661619 |
| 2 | MP0005451_abnormal_body_composition | 5.08880713 |
| 3 | MP0003646_muscle_fatigue | 4.78661026 |
| 4 | MP0002102_abnormal_ear_morphology | 4.73502792 |
| 5 | MP0003787_abnormal_imprinting | 4.48709770 |
| 6 | MP0002876_abnormal_thyroid_physiology | 4.02067903 |
| 7 | MP0005670_abnormal_white_adipose | 4.01595157 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.88001389 |
| 9 | MP0003693_abnormal_embryo_hatching | 3.53563082 |
| 10 | MP0003283_abnormal_digestive_organ | 3.51982029 |
| 11 | MP0008877_abnormal_DNA_methylation | 3.37048849 |
| 12 | MP0002653_abnormal_ependyma_morphology | 3.07913152 |
| 13 | MP0003121_genomic_imprinting | 3.05957052 |
| 14 | MP0005395_other_phenotype | 3.04244627 |
| 15 | MP0010094_abnormal_chromosome_stability | 2.91335988 |
| 16 | MP0005666_abnormal_adipose_tissue | 2.71811151 |
| 17 | MP0003699_abnormal_female_reproductive | 2.67972423 |
| 18 | MP0001119_abnormal_female_reproductive | 2.60648519 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.59221603 |
| 20 | MP0005365_abnormal_bile_salt | 2.56531980 |
| 21 | MP0003077_abnormal_cell_cycle | 2.55904439 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 2.49181697 |
| 23 | MP0000681_abnormal_thyroid_gland | 2.46894623 |
| 24 | MP0004130_abnormal_muscle_cell | 2.42919664 |
| 25 | MP0009278_abnormal_bone_marrow | 2.42218628 |
| 26 | MP0005408_hypopigmentation | 2.31939674 |
| 27 | MP0003123_paternal_imprinting | 2.29673278 |
| 28 | MP0002971_abnormal_brown_adipose | 2.27669099 |
| 29 | MP0003111_abnormal_nucleus_morphology | 2.26052445 |
| 30 | MP0006292_abnormal_olfactory_placode | 2.23282680 |
| 31 | MP0002249_abnormal_larynx_morphology | 2.12577984 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 2.04476750 |
| 33 | MP0005375_adipose_tissue_phenotype | 2.02554875 |
| 34 | MP0005220_abnormal_exocrine_pancreas | 2.00687086 |
| 35 | MP0001929_abnormal_gametogenesis | 2.00458132 |
| 36 | MP0000653_abnormal_sex_gland | 2.00321528 |
| 37 | MP0003195_calcinosis | 2.00228166 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.98863121 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.93645997 |
| 40 | MP0005360_urolithiasis | 1.89420214 |
| 41 | MP0005503_abnormal_tendon_morphology | 1.85849932 |
| 42 | MP0002210_abnormal_sex_determination | 1.83599092 |
| 43 | MP0003959_abnormal_lean_body | 1.81671951 |
| 44 | MP0000579_abnormal_nail_morphology | 1.79306762 |
| 45 | MP0003937_abnormal_limbs/digits/tail_de | 1.78220354 |
| 46 | MP0003122_maternal_imprinting | 1.67581536 |
| 47 | MP0001944_abnormal_pancreas_morphology | 1.66936695 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.64419555 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.63554899 |
| 50 | MP0000462_abnormal_digestive_system | 1.63380609 |
| 51 | MP0003868_abnormal_feces_composition | 1.59537836 |
| 52 | MP0008932_abnormal_embryonic_tissue | 1.59144817 |
| 53 | MP0005085_abnormal_gallbladder_physiolo | 1.58530761 |
| 54 | MP0010368_abnormal_lymphatic_system | 1.54842921 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.51963291 |
| 56 | MP0005409_darkened_coat_color | 1.49742890 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.47454389 |
| 58 | MP0003567_abnormal_fetal_cardiomyocyte | 1.43008815 |
| 59 | MP0002085_abnormal_embryonic_tissue | 1.41768258 |
| 60 | MP0005310_abnormal_salivary_gland | 1.41497314 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.41249435 |
| 62 | MP0003943_abnormal_hepatobiliary_system | 1.38266657 |
| 63 | MP0002928_abnormal_bile_duct | 1.38121914 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.37113597 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.37113597 |
| 66 | MP0002161_abnormal_fertility/fecundity | 1.35757379 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 1.33171090 |
| 68 | MP0001697_abnormal_embryo_size | 1.31164070 |
| 69 | MP0000350_abnormal_cell_proliferation | 1.29671469 |
| 70 | MP0001145_abnormal_male_reproductive | 1.29630425 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.29108765 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.26075698 |
| 73 | MP0001968_abnormal_touch/_nociception | 1.25889335 |
| 74 | MP0001661_extended_life_span | 1.25370018 |
| 75 | MP0001664_abnormal_digestion | 1.24922287 |
| 76 | MP0001730_embryonic_growth_arrest | 1.24538905 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 1.22990339 |
| 78 | MP0002970_abnormal_white_adipose | 1.22077191 |
| 79 | MP0005332_abnormal_amino_acid | 1.21633944 |
| 80 | MP0001915_intracranial_hemorrhage | 1.20092593 |
| 81 | MP0002084_abnormal_developmental_patter | 1.19535448 |
| 82 | MP0000639_abnormal_adrenal_gland | 1.19464216 |
| 83 | MP0009115_abnormal_fat_cell | 1.14207623 |
| 84 | MP0003252_abnormal_bile_duct | 1.14135067 |
| 85 | MP0001270_distended_abdomen | 1.13813178 |
| 86 | MP0003183_abnormal_peptide_metabolism | 1.13512359 |
| 87 | MP0005334_abnormal_fat_pad | 1.09519421 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 1.09093672 |
| 89 | MP0001672_abnormal_embryogenesis/_devel | 1.08809935 |
| 90 | MP0005380_embryogenesis_phenotype | 1.08809935 |
| 91 | MP0009672_abnormal_birth_weight | 1.07899464 |
| 92 | MP0005646_abnormal_pituitary_gland | 1.07622328 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 1.02006893 |
| 94 | MP0003690_abnormal_glial_cell | 0.99891311 |
| 95 | MP0001529_abnormal_vocalization | 0.99668569 |
| 96 | MP0003755_abnormal_palate_morphology | 0.99395683 |
| 97 | MP0002160_abnormal_reproductive_system | 0.97753630 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.96354994 |
| 99 | MP0005535_abnormal_body_temperature | 0.95989679 |
| 100 | MP0005452_abnormal_adipose_tissue | 0.95890237 |
| 101 | MP0005448_abnormal_energy_balance | 0.94972958 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.94935270 |
| 103 | MP0003953_abnormal_hormone_level | 0.93962873 |
| 104 | MP0001851_eye_inflammation | 0.93684806 |
| 105 | MP0005379_endocrine/exocrine_gland_phen | 0.92711861 |
| 106 | MP0001346_abnormal_lacrimal_gland | 0.92481804 |
| 107 | MP0003315_abnormal_perineum_morphology | 0.91812571 |
| 108 | MP0004043_abnormal_pH_regulation | 0.90715954 |
| 109 | MP0001881_abnormal_mammary_gland | 0.90415677 |
| 110 | MP0009697_abnormal_copulation | 0.88611754 |
| 111 | MP0003879_abnormal_hair_cell | 0.88287623 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.87419292 |
| 113 | MP0001905_abnormal_dopamine_level | 0.86485221 |
| 114 | MP0003633_abnormal_nervous_system | 0.84247396 |
| 115 | MP0002108_abnormal_muscle_morphology | 0.83975147 |
| 116 | MP0004858_abnormal_nervous_system | 0.83820422 |
| 117 | MP0001764_abnormal_homeostasis | 0.83802999 |
| 118 | MP0003890_abnormal_embryonic-extraembry | 0.82893496 |
| 119 | MP0009250_abnormal_appendicular_skeleto | 0.82504444 |
| 120 | MP0001188_hyperpigmentation | 0.82168924 |
| 121 | MP0010630_abnormal_cardiac_muscle | 0.82062734 |
| 122 | MP0001756_abnormal_urination | 0.82005248 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.81107267 |
| 124 | MP0008057_abnormal_DNA_replication | 0.80633422 |
| 125 | MP0004134_abnormal_chest_morphology | 0.80355491 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.79209820 |
| 127 | MP0000566_synostosis | 0.76452615 |
| 128 | MP0000609_abnormal_liver_physiology | 0.75820529 |
| 129 | MP0004510_myositis | 0.75165394 |
| 130 | MP0003984_embryonic_growth_retardation | 0.74799224 |
| 131 | MP0009379_abnormal_foot_pigmentation | 0.74731430 |
| 132 | MP0005551_abnormal_eye_electrophysiolog | 0.73938339 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.73805223 |
| 134 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72542452 |
| 135 | MP0003698_abnormal_male_reproductive | 0.71567080 |
| 136 | MP0001501_abnormal_sleep_pattern | 0.71302747 |
| 137 | MP0008058_abnormal_DNA_repair | 0.70909613 |
| 138 | MP0002116_abnormal_craniofacial_bone | 0.70337323 |
| 139 | MP0002932_abnormal_joint_morphology | 0.70084742 |
| 140 | MP0002088_abnormal_embryonic_growth/wei | 0.69949233 |
| 141 | MP0000598_abnormal_liver_morphology | 0.67742044 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.67621243 |
| 143 | MP0002009_preneoplasia | 0.67616051 |
| 144 | MP0003861_abnormal_nervous_system | 0.67492405 |
| 145 | MP0004197_abnormal_fetal_growth/weight/ | 0.67426431 |
| 146 | MP0000733_abnormal_muscle_development | 0.67351056 |
| 147 | MP0002086_abnormal_extraembryonic_tissu | 0.66876600 |
| 148 | MP0006138_congestive_heart_failure | 0.66727306 |
| 149 | MP0005621_abnormal_cell_physiology | 0.66469475 |
| 150 | MP0009384_cardiac_valve_regurgitation | 0.65811319 |
| 151 | MP0002909_abnormal_adrenal_gland | 0.64970619 |
| 152 | MP0000631_abnormal_neuroendocrine_gland | 0.64400524 |
| 153 | MP0003453_abnormal_keratinocyte_physiol | 0.63460060 |
| 154 | MP0005647_abnormal_sex_gland | 0.63452656 |
| 155 | MP0002177_abnormal_outer_ear | 0.62972759 |
| 156 | MP0000013_abnormal_adipose_tissue | 0.62760873 |
| 157 | MP0010307_abnormal_tumor_latency | 0.62609502 |
| 158 | MP0001919_abnormal_reproductive_system | 0.61921484 |
| 159 | MP0000432_abnormal_head_morphology | 0.61199021 |
| 160 | MP0003091_abnormal_cell_migration | 0.61140641 |
| 161 | MP0000678_abnormal_parathyroid_gland | 0.61138476 |
| 162 | MP0002638_abnormal_pupillary_reflex | 0.60982182 |
| 163 | MP0010030_abnormal_orbit_morphology | 0.60367312 |
| 164 | MP0003935_abnormal_craniofacial_develop | 0.60334700 |
| 165 | MP0004233_abnormal_muscle_weight | 0.60145143 |
| 166 | MP0000427_abnormal_hair_cycle | 0.60129852 |
| 167 | MP0010386_abnormal_urinary_bladder | 0.59906237 |
| 168 | MP0001849_ear_inflammation | 0.59693183 |
| 169 | MP0002822_catalepsy | 0.58933518 |
| 170 | MP0003942_abnormal_urinary_system | 0.58801877 |
| 171 | MP0004270_analgesia | 0.58585443 |
| 172 | MP0001324_abnormal_eye_pigmentation | 0.58330798 |
| 173 | MP0004859_abnormal_synaptic_plasticity | 0.58028500 |
| 174 | MP0002080_prenatal_lethality | 0.57373177 |
| 175 | MP0003763_abnormal_thymus_physiology | 0.57155356 |
| 176 | MP0000569_abnormal_digit_pigmentation | 0.56595346 |
| 177 | MP0003950_abnormal_plasma_membrane | 0.56202282 |
| 178 | MP0005187_abnormal_penis_morphology | 0.55649144 |
| 179 | MP0003136_yellow_coat_color | 0.55260546 |
| 180 | MP0001666_abnormal_nutrient_absorption | 0.55032074 |
| 181 | MP0002282_abnormal_trachea_morphology | 0.54940528 |
| 182 | MP0000490_abnormal_crypts_of | 0.54523321 |
| 183 | MP0000767_abnormal_smooth_muscle | 0.53908862 |
| 184 | MP0005384_cellular_phenotype | 0.52528199 |
| 185 | MP0002109_abnormal_limb_morphology | 0.52168902 |
| 186 | MP0005023_abnormal_wound_healing | 0.51974378 |
| 187 | MP0002168_other_aberrant_phenotype | 0.49536969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 6.53411756 |
| 2 | Cortical dysplasia (HP:0002539) | 5.93892036 |
| 3 | Male infertility (HP:0003251) | 5.75596229 |
| 4 | Thyroid-stimulating hormone excess (HP:0002925) | 5.15495242 |
| 5 | Chromsome breakage (HP:0040012) | 4.84109568 |
| 6 | Shawl scrotum (HP:0000049) | 4.82295079 |
| 7 | Flat capital femoral epiphysis (HP:0003370) | 4.67426549 |
| 8 | Acute myeloid leukemia (HP:0004808) | 4.30845308 |
| 9 | Facial hemangioma (HP:0000329) | 4.25475184 |
| 10 | Abnormality of the fingertips (HP:0001211) | 4.18799442 |
| 11 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.12661717 |
| 12 | Hyperthyroidism (HP:0000836) | 4.03571033 |
| 13 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.00120498 |
| 14 | Abnormality of the labia minora (HP:0012880) | 3.98626605 |
| 15 | Adrenal hypoplasia (HP:0000835) | 3.96095182 |
| 16 | Lip pit (HP:0100267) | 3.95039788 |
| 17 | Patellar aplasia (HP:0006443) | 3.85564512 |
| 18 | Ketoacidosis (HP:0001993) | 3.81762737 |
| 19 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.77594080 |
| 20 | Birth length less than 3rd percentile (HP:0003561) | 3.72553748 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.72156565 |
| 22 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.63528716 |
| 23 | Hypoglycemic seizures (HP:0002173) | 3.60554774 |
| 24 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.58484772 |
| 25 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.58484772 |
| 26 | Macroorchidism (HP:0000053) | 3.57772144 |
| 27 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.53385847 |
| 28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.53260122 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.52611442 |
| 30 | Large for gestational age (HP:0001520) | 3.49838396 |
| 31 | Thyroid carcinoma (HP:0002890) | 3.47459345 |
| 32 | Prolonged partial thromboplastin time (HP:0003645) | 3.35965252 |
| 33 | Hypercortisolism (HP:0001578) | 3.34328004 |
| 34 | Complement deficiency (HP:0004431) | 3.32675800 |
| 35 | Breast hypoplasia (HP:0003187) | 3.31869195 |
| 36 | Ketosis (HP:0001946) | 3.22345977 |
| 37 | Hyperglycemia (HP:0003074) | 3.18168031 |
| 38 | Capillary hemangiomas (HP:0005306) | 3.17772959 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.16514430 |
| 40 | Acute lymphatic leukemia (HP:0006721) | 3.16245660 |
| 41 | Sandal gap (HP:0001852) | 3.10694038 |
| 42 | Abnormality of chromosome segregation (HP:0002916) | 3.09926621 |
| 43 | Hypoglycemic coma (HP:0001325) | 3.08442790 |
| 44 | Sparse lateral eyebrow (HP:0005338) | 3.07109179 |
| 45 | Secondary amenorrhea (HP:0000869) | 3.05988041 |
| 46 | Abnormality of lateral ventricle (HP:0030047) | 2.93590764 |
| 47 | Hypergonadotropic hypogonadism (HP:0000815) | 2.92856507 |
| 48 | Arterial tortuosity (HP:0005116) | 2.92447399 |
| 49 | Neonatal hypoglycemia (HP:0001998) | 2.91388104 |
| 50 | Pulmonary fibrosis (HP:0002206) | 2.90524757 |
| 51 | Chronic bronchitis (HP:0004469) | 2.81796604 |
| 52 | Premature ovarian failure (HP:0008209) | 2.81572870 |
| 53 | Volvulus (HP:0002580) | 2.80594324 |
| 54 | Mesangial abnormality (HP:0001966) | 2.79871147 |
| 55 | Abnormal gallbladder physiology (HP:0012438) | 2.79448797 |
| 56 | Cholecystitis (HP:0001082) | 2.79448797 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.78840574 |
| 58 | Thoracic kyphosis (HP:0002942) | 2.72282465 |
| 59 | Abnormality of chromosome stability (HP:0003220) | 2.67866252 |
| 60 | Oligodactyly (hands) (HP:0001180) | 2.67250444 |
| 61 | Spondylolisthesis (HP:0003302) | 2.65904900 |
| 62 | Late onset (HP:0003584) | 2.61969920 |
| 63 | Diastasis recti (HP:0001540) | 2.59413777 |
| 64 | Breast aplasia (HP:0100783) | 2.53371770 |
| 65 | Midline defect of the nose (HP:0004122) | 2.52740935 |
| 66 | Vascular tortuosity (HP:0004948) | 2.51738400 |
| 67 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.51536809 |
| 68 | Overlapping toe (HP:0001845) | 2.48683822 |
| 69 | Retinal atrophy (HP:0001105) | 2.46458887 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.46235125 |
| 71 | Hyperglycinuria (HP:0003108) | 2.45678176 |
| 72 | Primary amenorrhea (HP:0000786) | 2.44480987 |
| 73 | Oligodactyly (HP:0012165) | 2.43296305 |
| 74 | Hypercholesterolemia (HP:0003124) | 2.41378777 |
| 75 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.38584011 |
| 76 | Malnutrition (HP:0004395) | 2.38234058 |
| 77 | Abnormality of glycine metabolism (HP:0010895) | 2.37413684 |
| 78 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.37413684 |
| 79 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.37049106 |
| 80 | Pigmentary retinal degeneration (HP:0001146) | 2.35740801 |
| 81 | Urethral obstruction (HP:0000796) | 2.34541159 |
| 82 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.30864963 |
| 83 | Joint hemorrhage (HP:0005261) | 2.30266196 |
| 84 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.28925058 |
| 85 | Infertility (HP:0000789) | 2.27133769 |
| 86 | Abnormality of the thoracic spine (HP:0100711) | 2.26725745 |
| 87 | Supernumerary spleens (HP:0009799) | 2.24937630 |
| 88 | Asymmetry of the thorax (HP:0001555) | 2.22714750 |
| 89 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.22261630 |
| 90 | Abnormality of the fovea (HP:0000493) | 2.22211001 |
| 91 | Camptodactyly of toe (HP:0001836) | 2.21006962 |
| 92 | Oligodontia (HP:0000677) | 2.20456772 |
| 93 | Prostate neoplasm (HP:0100787) | 2.19799160 |
| 94 | Hyperlipoproteinemia (HP:0010980) | 2.19644639 |
| 95 | Atrioventricular block (HP:0001678) | 2.19289271 |
| 96 | Abnormality of complement system (HP:0005339) | 2.18974839 |
| 97 | Villous atrophy (HP:0011473) | 2.18109726 |
| 98 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.18109726 |
| 99 | Abnormality of the aortic arch (HP:0012303) | 2.17159151 |
| 100 | Ectopic kidney (HP:0000086) | 2.16521807 |
| 101 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.15118460 |
| 102 | Neoplasm of the oral cavity (HP:0100649) | 2.14792120 |
| 103 | Anterior segment dysgenesis (HP:0007700) | 2.13733922 |
| 104 | Abnormality of the preputium (HP:0100587) | 2.11659359 |
| 105 | Adrenal overactivity (HP:0002717) | 2.09363589 |
| 106 | Abnormality of the femoral head (HP:0003368) | 2.08943280 |
| 107 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.08262936 |
| 108 | Truncal obesity (HP:0001956) | 2.07987336 |
| 109 | Impulsivity (HP:0100710) | 2.07334592 |
| 110 | Meckel diverticulum (HP:0002245) | 2.06974049 |
| 111 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.06744045 |
| 112 | Abnormality of femoral epiphyses (HP:0006499) | 2.06744045 |
| 113 | Testicular neoplasm (HP:0010788) | 2.02201008 |
| 114 | Potter facies (HP:0002009) | 2.01464210 |
| 115 | Facial shape deformation (HP:0011334) | 2.01464210 |
| 116 | Sloping forehead (HP:0000340) | 2.01363539 |
| 117 | Hyperpituitarism (HP:0010514) | 1.99444017 |
| 118 | Cystic hygroma (HP:0000476) | 1.98296885 |
| 119 | Neoplasm of the adrenal cortex (HP:0100641) | 1.98109313 |
| 120 | Hypoplastic iliac wings (HP:0002866) | 1.98020781 |
| 121 | Metaphyseal dysplasia (HP:0100255) | 1.97769023 |
| 122 | Hyperammonemia (HP:0001987) | 1.97107664 |
| 123 | Wrist flexion contracture (HP:0001239) | 1.94541824 |
| 124 | Xanthomatosis (HP:0000991) | 1.94100429 |
| 125 | Obstructive sleep apnea (HP:0002870) | 1.93537602 |
| 126 | Pseudobulbar signs (HP:0002200) | 1.92821739 |
| 127 | Hyperglycinemia (HP:0002154) | 1.92630931 |
| 128 | Goiter (HP:0000853) | 1.92298025 |
| 129 | Enlarged kidneys (HP:0000105) | 1.92127882 |
| 130 | Rhabdomyosarcoma (HP:0002859) | 1.91798755 |
| 131 | Unilateral renal agenesis (HP:0000122) | 1.90701947 |
| 132 | Abnormality of the ileum (HP:0001549) | 1.90581282 |
| 133 | Long toe (HP:0010511) | 1.90426643 |
| 134 | Clubbing of toes (HP:0100760) | 1.89541952 |
| 135 | Reduced antithrombin III activity (HP:0001976) | 1.88117917 |
| 136 | Short thumb (HP:0009778) | 1.87994409 |
| 137 | Chorioretinal atrophy (HP:0000533) | 1.87192132 |
| 138 | Chin dimple (HP:0010751) | 1.85734280 |
| 139 | Arachnodactyly (HP:0001166) | 1.84616265 |
| 140 | Enlarged penis (HP:0000040) | 1.84147493 |
| 141 | Medulloblastoma (HP:0002885) | 1.82678926 |
| 142 | Genetic anticipation (HP:0003743) | 1.82639751 |
| 143 | Mucopolysacchariduria (HP:0008155) | 1.82198917 |
| 144 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82198917 |
| 145 | Depressed nasal tip (HP:0000437) | 1.82143868 |
| 146 | Cerebellar dysplasia (HP:0007033) | 1.81759965 |
| 147 | Duodenal stenosis (HP:0100867) | 1.81043414 |
| 148 | Small intestinal stenosis (HP:0012848) | 1.81043414 |
| 149 | Thickened helices (HP:0000391) | 1.78333869 |
| 150 | Molar tooth sign on MRI (HP:0002419) | 1.77120065 |
| 151 | Abnormality of midbrain morphology (HP:0002418) | 1.77120065 |
| 152 | Abnormality of the common coagulation pathway (HP:0010990) | 1.77110947 |
| 153 | Osteomalacia (HP:0002749) | 1.76745027 |
| 154 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.76674198 |
| 155 | Hypoplasia of the fovea (HP:0007750) | 1.76674198 |
| 156 | Retrobulbar optic neuritis (HP:0100654) | 1.76662479 |
| 157 | Optic neuritis (HP:0100653) | 1.76662479 |
| 158 | Rib fusion (HP:0000902) | 1.76325998 |
| 159 | Absent radius (HP:0003974) | 1.76314923 |
| 160 | Myelodysplasia (HP:0002863) | 1.75354297 |
| 161 | Insulin resistance (HP:0000855) | 1.75186131 |
| 162 | Fibular aplasia (HP:0002990) | 1.74784005 |
| 163 | Dicarboxylic aciduria (HP:0003215) | 1.74644185 |
| 164 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74644185 |
| 165 | Delayed CNS myelination (HP:0002188) | 1.73823853 |
| 166 | Abnormality of the columella (HP:0009929) | 1.72748112 |
| 167 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.70957636 |
| 168 | Intestinal atresia (HP:0011100) | 1.70736014 |
| 169 | Venous insufficiency (HP:0005293) | 1.69665470 |
| 170 | Aplasia involving forearm bones (HP:0009822) | 1.69227054 |
| 171 | Absent forearm bone (HP:0003953) | 1.69227054 |
| 172 | Atelectasis (HP:0100750) | 1.68925908 |
| 173 | Abnormality of the intervertebral disk (HP:0005108) | 1.68767052 |
| 174 | Cafe-au-lait spot (HP:0000957) | 1.67720468 |
| 175 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.67440364 |
| 176 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.67440364 |
| 177 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.67440364 |
| 178 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.66782699 |
| 179 | Polygenic inheritance (HP:0010982) | 1.64346777 |
| 180 | Exercise-induced myalgia (HP:0003738) | 1.63082509 |
| 181 | Abnormal pancreas size (HP:0012094) | 1.61570121 |
| 182 | Polydipsia (HP:0001959) | 1.60923131 |
| 183 | Abnormal drinking behavior (HP:0030082) | 1.60923131 |
| 184 | Symptomatic seizures (HP:0011145) | 1.60376776 |
| 185 | Lymphangioma (HP:0100764) | 1.59625521 |
| 186 | Growth hormone excess (HP:0000845) | 1.58759917 |
| 187 | Systemic lupus erythematosus (HP:0002725) | 1.56759704 |
| 188 | Back pain (HP:0003418) | 1.56754814 |
| 189 | Abnormality of the vitreous humor (HP:0004327) | 1.56552156 |
| 190 | Lower limb asymmetry (HP:0100559) | 1.54513859 |
| 191 | Asymmetric septal hypertrophy (HP:0001670) | 1.53427448 |
| 192 | Craniofacial hyperostosis (HP:0004493) | 1.51966817 |
| 193 | Increased circulating renin level (HP:0000848) | 1.50708891 |
| 194 | Truncal ataxia (HP:0002078) | 1.49375681 |
| 195 | Dysdiadochokinesis (HP:0002075) | 1.48926131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.34145649 |
| 2 | LATS1 | 4.25630306 |
| 3 | MAP3K6 | 3.67083722 |
| 4 | LATS2 | 3.64193999 |
| 5 | PLK4 | 3.49067009 |
| 6 | ERN1 | 3.42940875 |
| 7 | EEF2K | 3.32064742 |
| 8 | ERBB4 | 3.21630787 |
| 9 | BRAF | 3.19098185 |
| 10 | KSR2 | 3.18358467 |
| 11 | MUSK | 3.12226046 |
| 12 | TRIB3 | 3.03888543 |
| 13 | TAOK1 | 2.97254585 |
| 14 | MAP3K9 | 2.93148427 |
| 15 | STK38L | 2.72295592 |
| 16 | TTK | 2.61909878 |
| 17 | MOS | 2.49597726 |
| 18 | MAP3K13 | 2.45782207 |
| 19 | ICK | 2.44889405 |
| 20 | PASK | 2.37155207 |
| 21 | CDC7 | 2.34691938 |
| 22 | FRK | 2.24429222 |
| 23 | CAMK1G | 2.23728727 |
| 24 | RAF1 | 2.23308456 |
| 25 | SMG1 | 2.10123836 |
| 26 | ARAF | 2.09800210 |
| 27 | ADRBK2 | 2.08106594 |
| 28 | HIPK2 | 2.04325206 |
| 29 | MAPKAPK3 | 2.03292564 |
| 30 | SIK1 | 1.88365466 |
| 31 | PNCK | 1.87678872 |
| 32 | CAMK1D | 1.82532271 |
| 33 | MAP3K10 | 1.78254983 |
| 34 | CHEK2 | 1.75695280 |
| 35 | STK3 | 1.65149322 |
| 36 | TAF1 | 1.59918692 |
| 37 | CDK8 | 1.55155159 |
| 38 | PRKD3 | 1.52613865 |
| 39 | VRK2 | 1.51501886 |
| 40 | AKT3 | 1.50041160 |
| 41 | KSR1 | 1.47933280 |
| 42 | MELK | 1.45751470 |
| 43 | BMPR2 | 1.45599692 |
| 44 | CDK9 | 1.40475991 |
| 45 | NEK2 | 1.37540599 |
| 46 | MAPK7 | 1.34940403 |
| 47 | PAK6 | 1.30352252 |
| 48 | MAP3K4 | 1.22106862 |
| 49 | MAPK13 | 1.21663959 |
| 50 | MAPKAPK5 | 1.18288624 |
| 51 | FGFR2 | 1.15608921 |
| 52 | STK10 | 1.13837677 |
| 53 | PRKD2 | 1.12686211 |
| 54 | DAPK2 | 1.12208401 |
| 55 | IRAK3 | 1.10668089 |
| 56 | TYRO3 | 1.09764480 |
| 57 | WNK4 | 1.07234513 |
| 58 | PHKG1 | 1.03672415 |
| 59 | PHKG2 | 1.03672415 |
| 60 | RIPK1 | 1.03210829 |
| 61 | CDK6 | 0.99654992 |
| 62 | DMPK | 0.98117425 |
| 63 | PDGFRA | 0.96660160 |
| 64 | PLK1 | 0.94014572 |
| 65 | CDK12 | 0.90059002 |
| 66 | NTRK2 | 0.87283809 |
| 67 | MAP2K7 | 0.86512849 |
| 68 | KIT | 0.86487490 |
| 69 | WNK1 | 0.86173373 |
| 70 | RPS6KL1 | 0.84739462 |
| 71 | RPS6KC1 | 0.84739462 |
| 72 | RPS6KB2 | 0.84094510 |
| 73 | MAP3K8 | 0.83663223 |
| 74 | RPS6KA6 | 0.83118468 |
| 75 | PRKAA2 | 0.82432753 |
| 76 | TRPM7 | 0.79826956 |
| 77 | STK38 | 0.79052493 |
| 78 | DYRK2 | 0.78314174 |
| 79 | PRKCH | 0.78024393 |
| 80 | MARK2 | 0.76459406 |
| 81 | PAK2 | 0.75123939 |
| 82 | CAMK1 | 0.74945047 |
| 83 | BCKDK | 0.74243478 |
| 84 | DYRK1A | 0.71785822 |
| 85 | ACVR1B | 0.70251396 |
| 86 | RET | 0.69722867 |
| 87 | MAP2K3 | 0.69521369 |
| 88 | PRKAA1 | 0.69028033 |
| 89 | FLT3 | 0.68020738 |
| 90 | MKNK1 | 0.68010789 |
| 91 | CSNK1G1 | 0.67770638 |
| 92 | MAP2K2 | 0.65148035 |
| 93 | BRD4 | 0.63866509 |
| 94 | ABL2 | 0.62707477 |
| 95 | AURKB | 0.62681674 |
| 96 | MAP2K4 | 0.62489409 |
| 97 | FGFR3 | 0.62228078 |
| 98 | PRKCG | 0.62109827 |
| 99 | PDPK1 | 0.59969288 |
| 100 | RPS6KA2 | 0.58532163 |
| 101 | MAPK4 | 0.58452768 |
| 102 | SGK1 | 0.58101052 |
| 103 | CHEK1 | 0.57407643 |
| 104 | MAPK3 | 0.55761464 |
| 105 | MAPK12 | 0.54556894 |
| 106 | MAPK15 | 0.54480783 |
| 107 | TIE1 | 0.53485688 |
| 108 | STK24 | 0.53353521 |
| 109 | IRAK1 | 0.53320224 |
| 110 | AURKA | 0.50698896 |
| 111 | RPS6KA3 | 0.50683536 |
| 112 | SGK2 | 0.50142866 |
| 113 | TGFBR1 | 0.48938471 |
| 114 | CDK3 | 0.48811661 |
| 115 | ADRBK1 | 0.48335474 |
| 116 | MAP3K2 | 0.47761589 |
| 117 | GSK3A | 0.47403935 |
| 118 | MAP3K5 | 0.47141435 |
| 119 | NLK | 0.47074219 |
| 120 | * GSK3B | 0.46854351 |
| 121 | NUAK1 | 0.46614473 |
| 122 | CSNK1G2 | 0.46560539 |
| 123 | UHMK1 | 0.44898102 |
| 124 | ATM | 0.44131243 |
| 125 | MAP3K7 | 0.43871333 |
| 126 | RPS6KB1 | 0.43185653 |
| 127 | CAMK4 | 0.41141141 |
| 128 | CDK4 | 0.33413544 |
| 129 | CSNK1G3 | 0.33261103 |
| 130 | ABL1 | 0.33064869 |
| 131 | CDK7 | 0.32870434 |
| 132 | MAPK11 | 0.31702134 |
| 133 | PINK1 | 0.31232288 |
| 134 | MAP3K1 | 0.31165170 |
| 135 | SGK494 | 0.30321539 |
| 136 | SGK223 | 0.30321539 |
| 137 | BUB1 | 0.29090789 |
| 138 | PLK3 | 0.28959006 |
| 139 | NEK9 | 0.28409282 |
| 140 | RPS6KA4 | 0.28386172 |
| 141 | BMPR1B | 0.27954717 |
| 142 | CDK1 | 0.26481584 |
| 143 | CDK2 | 0.24923359 |
| 144 | MAPK10 | 0.21043325 |
| 145 | SGK3 | 0.20542713 |
| 146 | EPHA3 | 0.19999646 |
| 147 | NEK1 | 0.19142720 |
| 148 | MAP2K1 | 0.19059994 |
| 149 | CAMK2A | 0.18836945 |
| 150 | AKT1 | 0.18016631 |
| 151 | CSNK1A1L | 0.17925262 |
| 152 | CSNK1D | 0.17476743 |
| 153 | MAPK14 | 0.15216406 |
| 154 | MTOR | 0.14529662 |
| 155 | MAP3K12 | 0.13864554 |
| 156 | MAPK1 | 0.12953864 |
| 157 | PLK2 | 0.11751630 |
| 158 | JAK2 | 0.11187072 |
| 159 | CHUK | 0.10854098 |
| 160 | PAK1 | 0.10770139 |
| 161 | JAK3 | 0.09614213 |
| 162 | STK4 | 0.08156729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 4.09760149 |
| 2 | Cell cycle_Homo sapiens_hsa04110 | 4.02757237 |
| 3 | RNA degradation_Homo sapiens_hsa03018 | 3.63195283 |
| 4 | Basal transcription factors_Homo sapiens_hsa03022 | 3.00050909 |
| 5 | Circadian rhythm_Homo sapiens_hsa04710 | 2.92122062 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.86422319 |
| 7 | Pancreatic cancer_Homo sapiens_hsa05212 | 2.66790087 |
| 8 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 2.53418908 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.50397252 |
| 10 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.42044172 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.36514347 |
| 12 | p53 signaling pathway_Homo sapiens_hsa04115 | 2.32278580 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.31099772 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23312833 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.18288070 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.17714769 |
| 17 | Oocyte meiosis_Homo sapiens_hsa04114 | 2.16430315 |
| 18 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 2.10320717 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.03765697 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.02631440 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02190084 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.90943498 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.90829282 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.88999289 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.85259792 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.82826570 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.73481238 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72756765 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.71718289 |
| 30 | Colorectal cancer_Homo sapiens_hsa05210 | 1.68626889 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.68557210 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.68423523 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.66578256 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.65591382 |
| 35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.62080978 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.61265071 |
| 37 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.58465789 |
| 38 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.57718400 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.57570977 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57288881 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.55337573 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.54168057 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54029130 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.52274490 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.52001975 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.51902180 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49938535 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 1.45370324 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45317586 |
| 50 | Base excision repair_Homo sapiens_hsa03410 | 1.43683091 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42277641 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.39749947 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39099482 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34942877 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.32711355 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 1.32592371 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.31923759 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.30788458 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.26768719 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23429888 |
| 61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.21571444 |
| 62 | Endometrial cancer_Homo sapiens_hsa05213 | 1.20940164 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.19360318 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19271038 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 1.15402197 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.15199906 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.11269806 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10261222 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10218865 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.09562018 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09298577 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09169015 |
| 73 | Insulin secretion_Homo sapiens_hsa04911 | 1.07748051 |
| 74 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.07494705 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 1.07044746 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 1.06536722 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00866634 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 1.00837795 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.00254330 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00097270 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99712250 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.95996129 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.95955798 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93021675 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90326458 |
| 86 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.89844820 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.89400678 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89289470 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87540637 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87470383 |
| 91 | Mismatch repair_Homo sapiens_hsa03430 | 0.85965144 |
| 92 | DNA replication_Homo sapiens_hsa03030 | 0.85539725 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85308621 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85017207 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.84941116 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83241573 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.80972075 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80156648 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.80070476 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79016162 |
| 101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78743094 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78419465 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76731597 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76250064 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.75094202 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.74503011 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71851820 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70977675 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.70198768 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68343113 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68183916 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67687968 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66152509 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.63612553 |
| 115 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62315489 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62254498 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60563940 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.60318683 |
| 119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60151786 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59688176 |
| 121 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59456255 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57334465 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57296581 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55806739 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55077864 |
| 126 | RNA polymerase_Homo sapiens_hsa03020 | 0.55053885 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.54831839 |
| 128 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53357658 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52285929 |
| 130 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51284118 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50225904 |
| 132 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49384315 |
| 133 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49275927 |
| 134 | Salivary secretion_Homo sapiens_hsa04970 | 0.49199819 |
| 135 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48814106 |
| 136 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47840312 |
| 137 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47692689 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47679665 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47384810 |
| 140 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46755581 |
| 141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45640535 |
| 142 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45453359 |
| 143 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45437498 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45285225 |
| 145 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45233385 |
| 146 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.42260264 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42120105 |
| 148 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41477595 |
| 149 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41028251 |
| 150 | Long-term potentiation_Homo sapiens_hsa04720 | 0.40281841 |
| 151 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.39777159 |
| 152 | Melanoma_Homo sapiens_hsa05218 | 0.38571274 |
| 153 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38540527 |
| 154 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38261330 |
| 155 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33191505 |
| 156 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32189365 |
| 157 | Shigellosis_Homo sapiens_hsa05131 | 0.32058742 |
| 158 | Platelet activation_Homo sapiens_hsa04611 | 0.29004896 |
| 159 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25559894 |
| 160 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.24773941 |
| 161 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24021175 |
| 162 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23111736 |
| 163 | Gap junction_Homo sapiens_hsa04540 | 0.22643569 |
| 164 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.22456646 |
| 165 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.21480979 |
| 166 | Tight junction_Homo sapiens_hsa04530 | 0.20777198 |
| 167 | Purine metabolism_Homo sapiens_hsa00230 | 0.17801878 |
| 168 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17539391 |
| 169 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.15041711 |
| 170 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15031377 |
| 171 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.14344061 |

